Literature DB >> 1423205

Does cancer survival differ for older patients?

A K Kant1, C Glover, J Horm, A Schatzkin, T B Harris.   

Abstract

The relation of age to 5-year relative survival rates was examined for leading sites of cancer resulting in death among 127,554 patients; data from 1978 to 1982 were studied for four areas of the Surveillance, Epidemiology and End Results program of the National Cancer Institute. Overall and stage-stratified relative survival rates declined with advancing patient age for cancer of the lung, prostate, pancreas, bladder, oral cavity, uterus, cervix, ovary, and large bowel (women only). In men, this trend was not explained by age differences in stage of diagnosis, whereas, among women, age was associated with more advanced disease for most sites examined. Although overall survival rates were lower in black patients compared with white patients, the age-survival and age-stage trends were similar in the two racial groups.

Entities:  

Mesh:

Year:  1992        PMID: 1423205     DOI: 10.1002/1097-0142(19921201)70:11<2734::aid-cncr2820701127>3.0.co;2-f

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

Review 1.  Age-related racial disparities in prostate cancer patients: A systematic review.

Authors:  Ting He; C Daniel Mullins
Journal:  Ethn Health       Date:  2016-10-05       Impact factor: 2.772

Review 2.  Common cancers in the elderly.

Authors:  J Hansen
Journal:  Drugs Aging       Date:  1998-12       Impact factor: 3.923

3.  Prostatic carcinoma: a multivariate analysis of prognostic factors.

Authors:  A Berner; S Harvei; S Tretli; S D Fosså; J M Nesland
Journal:  Br J Cancer       Date:  1994-05       Impact factor: 7.640

4.  Differences in treatment and survival rates of non-small-cell lung cancer in three regions of France.

Authors:  P Grosclaude; J P Galat; J Macé-Lesech; M Roumagnac-Machelard; M Mercier; J Robillard
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.